drugset / Trial / NCT04150549
FMT for MS Patients
Phase 2
Unknown
34 enrolled
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
RandomizedParallel-groupDouble-blindBasic science
Summary
This is a placebo-controlled, double-blinded, randomized trial design, whereby all patients are eligible to start an injectable therapy, and then randomized to either placebo or FMT for approximately 1 year.
Timeline
- Start
- 2023-06
- Primary completion
- 2025-05
- Completion
- 2025-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Fecal Microbial Transplants | Unknown | — | Oral |